Katie Headland is a strategic leader in drug discovery with over 20 years of experience, currently serving as VP of Business Development at Axxam. She specializes in creating partnerships to advance programs from target validation to lead optimization, leveraging her PhD in Nutritional Biochemistry from the University of Nottingham.
There is no publicly available information regarding Katies personal life or hobbies, as her profile focuses entirely on her extensive professional background in the pharmaceutical and biotech industries.
She has co-authored several scientific publications, particularly on therapies for obesity and diabetes during her time as a preclinical project leader.
Read the full overview →They prefer to do thorough analysis of any situation. They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.